<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Medicine/Health &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/medicine-health/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 26 Jul 2021 15:40:53 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Medicine/Health &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Exosome formulation developed to deliver antibodies for choroidal neovascularization therapy</title>
		<link>https://bioengineer.org/exosome-formulation-developed-to-deliver-antibodies-for-choroidal-neovascularization-therapy/</link>
					<comments>https://bioengineer.org/exosome-formulation-developed-to-deliver-antibodies-for-choroidal-neovascularization-therapy/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 26 Jul 2021 15:40:53 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Biomedical/Environmental/Chemical Engineering]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Ophthalmology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/exosome-formulation-developed-to-deliver-antibodies-for-choroidal-neovascularization-therapy/</guid>

					<description><![CDATA[Credit: TIAN Ying and ZHANG Fan Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences, Beijing Chaoyang Hospital and the University of Queensland have developed a new formulation based on regulatory T-cell exosomes (rEXS) to deliver vascular endothelial growth factor (VEGF) antibodies for choroidal neovascularization therapy. The study was published [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/exosome-formulation-developed-to-deliver-antibodies-for-choroidal-neovascularization-therapy/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174533</post-id>	</item>
		<item>
		<title>Improving air quality reduces dementia risk, multiple studies suggest</title>
		<link>https://bioengineer.org/improving-air-quality-reduces-dementia-risk-multiple-studies-suggest/</link>
					<comments>https://bioengineer.org/improving-air-quality-reduces-dementia-risk-multiple-studies-suggest/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 26 Jul 2021 14:43:39 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Alzheimer]]></category>
		<category><![CDATA[Environmental Health]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/improving-air-quality-reduces-dementia-risk-multiple-studies-suggest/</guid>

					<description><![CDATA[Credit: Alzheimer&#8217;s Association DENVER, JULY 26, 2021 &#8212; Improving air quality may improve cognitive function and reduce dementia risk, according to several studies reported today at the Alzheimer&#8217;s Association International Conference® (AAIC®) 2021 in Denver and virtually. Previous reports have linked long-term air pollution exposure with accumulation of Alzheimer&#8217;s disease-related brain plaques, but this is [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/improving-air-quality-reduces-dementia-risk-multiple-studies-suggest/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174531</post-id>	</item>
		<item>
		<title>Elsevier partners with American College of Medical Genetics and Genomics to publish Genetics in Medicine</title>
		<link>https://bioengineer.org/elsevier-partners-with-american-college-of-medical-genetics-and-genomics-to-publish-genetics-in-medicine/</link>
					<comments>https://bioengineer.org/elsevier-partners-with-american-college-of-medical-genetics-and-genomics-to-publish-genetics-in-medicine/#comments</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 26 Jul 2021 13:38:22 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Collaboration]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/elsevier-partners-with-american-college-of-medical-genetics-and-genomics-to-publish-genetics-in-medicine/</guid>

					<description><![CDATA[Collaboration signifies strong commitment by all stakeholders to maintain the journal&#8217;s high standards and expand its global prominence Credit: ACMG New York, July 26, 2021 &#8211; The American College of Medical Genetics and Genomics (ACMG), the only nationally recognized US medical professional organization solely dedicated to improving health through the practice of medical genetics and [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/elsevier-partners-with-american-college-of-medical-genetics-and-genomics-to-publish-genetics-in-medicine/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174529</post-id>	</item>
		<item>
		<title>Goal-setting and positive parent-child relationships reduce risk of youth vaping</title>
		<link>https://bioengineer.org/goal-setting-and-positive-parent-child-relationships-reduce-risk-of-youth-vaping/</link>
					<comments>https://bioengineer.org/goal-setting-and-positive-parent-child-relationships-reduce-risk-of-youth-vaping/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 26 Jul 2021 04:38:07 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Addiction]]></category>
		<category><![CDATA[Epidemiology]]></category>
		<category><![CDATA[Health Professionals]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<category><![CDATA[Social/Behavioral Science]]></category>
		<guid isPermaLink="false">https://bioengineer.org/goal-setting-and-positive-parent-child-relationships-reduce-risk-of-youth-vaping/</guid>

					<description><![CDATA[Credit: UPMC PITTSBURGH, July 26, 2021 &#8211; Adolescents who set goals for their future and those with strong parental support are less likely to use e-cigarettes and other tobacco products, according to a study by UPMC Children&#8217;s Hospital of Pittsburgh and University of Pittsburgh School of Medicine physician-scientists. The research, published today in the journal [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/goal-setting-and-positive-parent-child-relationships-reduce-risk-of-youth-vaping/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174520</post-id>	</item>
		<item>
		<title>Using silicone wristbands to measure air quality</title>
		<link>https://bioengineer.org/using-silicone-wristbands-to-measure-air-quality/</link>
					<comments>https://bioengineer.org/using-silicone-wristbands-to-measure-air-quality/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 19:34:41 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pollution/Remediation]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Toxicology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/using-silicone-wristbands-to-measure-air-quality/</guid>

					<description><![CDATA[A Texas A&#038;M study found that these inexpensive, convenient devices can measure exposure to a class of chemicals that can be harmful during pregnancy Credit: Itza Mendoza-Sanchez A study by researchers at the Texas A&#038;M University School of Public Health shows that inexpensive and convenient devices such as silicone wristbands can be used to yield [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/using-silicone-wristbands-to-measure-air-quality/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174500</post-id>	</item>
		<item>
		<title>New organ-on-a-chip finds crucial interaction between blood, ovarian cancer tumors</title>
		<link>https://bioengineer.org/new-organ-on-a-chip-finds-crucial-interaction-between-blood-ovarian-cancer-tumors/</link>
					<comments>https://bioengineer.org/new-organ-on-a-chip-finds-crucial-interaction-between-blood-ovarian-cancer-tumors/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 18:56:09 +0000</pubDate>
				<category><![CDATA[Science News]]></category>
		<category><![CDATA[Biomedical/Environmental/Chemical Engineering]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/new-organ-on-a-chip-finds-crucial-interaction-between-blood-ovarian-cancer-tumors/</guid>

					<description><![CDATA[Team identifies crucial interaction between platelets and tumors for the first time Credit: Texas A&#038;M Engineering In the evolving field of cancer biology and treatment, innovations in organ-on-a-chip microdevices allow researchers to discover more about the disease outside the human body. These organs-on-chips serve as a model of the state an actual cancer patient is [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/new-organ-on-a-chip-finds-crucial-interaction-between-blood-ovarian-cancer-tumors/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174495</post-id>	</item>
		<item>
		<title>Advantages of intranasal vaccination against SARS-CoV-2</title>
		<link>https://bioengineer.org/advantages-of-intranasal-vaccination-against-sars-cov-2/</link>
					<comments>https://bioengineer.org/advantages-of-intranasal-vaccination-against-sars-cov-2/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 17:40:38 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Virology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/advantages-of-intranasal-vaccination-against-sars-cov-2/</guid>

					<description><![CDATA[Intranasal vaccination is needle-free and elicits immunity at the site of infection, the respiratory tract Credit: UAB BIRMINGHAM, Ala. &#8211; There are many reasons that an intranasal vaccine against the SARS-CoV-2 virus would be helpful in the fight against COVID-19 infections, University of Alabama at Birmingham immunologists Fran Lund, Ph.D., and Troy Randall, Ph.D., write [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/advantages-of-intranasal-vaccination-against-sars-cov-2/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174491</post-id>	</item>
		<item>
		<title>Neuroscientists posit that brain region is a key locus of learning</title>
		<link>https://bioengineer.org/neuroscientists-posit-that-brain-region-is-a-key-locus-of-learning/</link>
					<comments>https://bioengineer.org/neuroscientists-posit-that-brain-region-is-a-key-locus-of-learning/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 17:20:54 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Alzheimer]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[neurobiology]]></category>
		<category><![CDATA[Physiology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/neuroscientists-posit-that-brain-region-is-a-key-locus-of-learning/</guid>

					<description><![CDATA[Credit: Sur Lab/ MIT Picower Institute Small and seemingly specialized, the brain&#8217;s locus coeruleus (LC) region has been stereotyped for its outsized export of the arousal-stimulating neuromodulator norepinephrine. In a new paper and with a new grant from the National Institutes of Health, an MIT neuroscience lab is making the case that the LC is [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/neuroscientists-posit-that-brain-region-is-a-key-locus-of-learning/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174489</post-id>	</item>
		<item>
		<title>Four themes identified as contributors to diseases of despair in Pennsylvania</title>
		<link>https://bioengineer.org/four-themes-identified-as-contributors-to-diseases-of-despair-in-pennsylvania/</link>
					<comments>https://bioengineer.org/four-themes-identified-as-contributors-to-diseases-of-despair-in-pennsylvania/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 15:54:27 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Addiction]]></category>
		<category><![CDATA[Behavior]]></category>
		<category><![CDATA[Death/Dying]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Mental Health]]></category>
		<category><![CDATA[Social/Behavioral Science]]></category>
		<guid isPermaLink="false">https://bioengineer.org/four-themes-identified-as-contributors-to-diseases-of-despair-in-pennsylvania/</guid>

					<description><![CDATA[Credit: Penn State Hershey, Pa. &#8212; Financial instability, lack of infrastructure, a deteriorating sense of community and family fragmentation are key contributors to diseases of despair in Pennsylvania communities, according to Penn State College of Medicine and Highmark Health researchers. The researchers conducted four focus groups in Pennsylvania communities identified as having high rates of [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/four-themes-identified-as-contributors-to-diseases-of-despair-in-pennsylvania/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174485</post-id>	</item>
		<item>
		<title>Why do some people get severe COVID-19? The nose may know</title>
		<link>https://bioengineer.org/why-do-some-people-get-severe-covid-19-the-nose-may-know/</link>
					<comments>https://bioengineer.org/why-do-some-people-get-severe-covid-19-the-nose-may-know/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 15:46:24 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Cell Biology]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Public Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/why-do-some-people-get-severe-covid-19-the-nose-may-know/</guid>

					<description><![CDATA[People who develop severe COVID-19 have markedly blunted antiviral responses in the nasopharynx Credit: BioRxiv Feb 20, 2021, https://doi.org/10.1101/2021.02.20.431155 The body&#8217;s first encounter with SARS-CoV-2, the virus behind COVID-19, happens in the nose and throat, or nasopharynx. A new study in the journal Cell suggests that the first responses in this battleground help determine who [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/why-do-some-people-get-severe-covid-19-the-nose-may-know/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174481</post-id>	</item>
		<item>
		<title>Featured articles from the journal CHEST®, July 2021</title>
		<link>https://bioengineer.org/featured-articles-from-the-journal-chest-july-2021/</link>
					<comments>https://bioengineer.org/featured-articles-from-the-journal-chest-july-2021/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 15:38:06 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Critical Care/Emergency Medicine]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<category><![CDATA[Sleep/Sleep Disorders]]></category>
		<guid isPermaLink="false">https://bioengineer.org/featured-articles-from-the-journal-chest-july-2021/</guid>

					<description><![CDATA[Credit: González Gutiérrez J., et al, Journal CHEST® Glenview, Ill. &#8211; Published monthly, the journal CHEST® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care, sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonology and cardiology, sleep, and thoracic oncology. [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/featured-articles-from-the-journal-chest-july-2021/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174479</post-id>	</item>
		<item>
		<title>&#8216;Feel good&#8217; brain messenger can be willfully controlled, new study reveals</title>
		<link>https://bioengineer.org/feel-good-brain-messenger-can-be-willfully-controlled-new-study-reveals/</link>
					<comments>https://bioengineer.org/feel-good-brain-messenger-can-be-willfully-controlled-new-study-reveals/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 15:18:47 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[neurobiology]]></category>
		<category><![CDATA[Neurochemistry]]></category>
		<guid isPermaLink="false">https://bioengineer.org/feel-good-brain-messenger-can-be-willfully-controlled-new-study-reveals/</guid>

					<description><![CDATA[Neuroscientists show that mice can learn to manipulate random dopamine impulses for reward Credit: Julia Kuhl From the thrill of hearing an ice cream truck approaching to the spikes of pleasure while sipping a fine wine, the neurological messenger known as dopamine has been popularly described as the brain&#8217;s &#8220;feel good&#8221; chemical related to reward [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/feel-good-brain-messenger-can-be-willfully-controlled-new-study-reveals/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174477</post-id>	</item>
		<item>
		<title>UMass Amherst grad student awarded fellowship for food allergy research</title>
		<link>https://bioengineer.org/umass-amherst-grad-student-awarded-fellowship-for-food-allergy-research/</link>
					<comments>https://bioengineer.org/umass-amherst-grad-student-awarded-fellowship-for-food-allergy-research/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 15:00:35 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Environmental Health]]></category>
		<category><![CDATA[Epidemiology]]></category>
		<category><![CDATA[Food/Food Science]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Microbiology]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Virology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/umass-amherst-grad-student-awarded-fellowship-for-food-allergy-research/</guid>

					<description><![CDATA[USDA program focuses on developing next generation of food scientists Credit: UMass Amherst University of Massachusetts Amherst food science Ph.D. candidate Cassandra Suther has received a prestigious predoctoral fellowship of $180,000 from the U.S. Department of Agriculture&#8217;s National Institute of Food and Agriculture (USDA-NIFA) to study the effect of norovirus on the development and severity [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/umass-amherst-grad-student-awarded-fellowship-for-food-allergy-research/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174475</post-id>	</item>
		<item>
		<title>Novel imaging agent identifies biomarker for iron-targeted cancer therapies</title>
		<link>https://bioengineer.org/novel-imaging-agent-identifies-biomarker-for-iron-targeted-cancer-therapies/</link>
					<comments>https://bioengineer.org/novel-imaging-agent-identifies-biomarker-for-iron-targeted-cancer-therapies/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 14:57:33 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Diagnostics]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/novel-imaging-agent-identifies-biomarker-for-iron-targeted-cancer-therapies/</guid>

					<description><![CDATA[Credit: Image created by Evans, Renslo et al. University of California San Francisco. Reston, VA&#8211;A new radiotracer that detects iron in cancer cells has proven effective, opening the door for the advancement of iron-targeted therapies for cancer patients. The radiotracer, 18F-TRX, can be used to measure iron concentration in tumors, which can help predict whether [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/novel-imaging-agent-identifies-biomarker-for-iron-targeted-cancer-therapies/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174473</post-id>	</item>
		<item>
		<title>New insights into immune responses to malaria</title>
		<link>https://bioengineer.org/new-insights-into-immune-responses-to-malaria/</link>
					<comments>https://bioengineer.org/new-insights-into-immune-responses-to-malaria/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 14:49:28 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Algorithms/Models]]></category>
		<category><![CDATA[Disease in the Developing World]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Mathematics/Statistics]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Vaccines]]></category>
		<guid isPermaLink="false">https://bioengineer.org/new-insights-into-immune-responses-to-malaria/</guid>

					<description><![CDATA[Credit: WEHI, Australia Advanced technologies have been used to solve a long-standing mystery about why some people develop serious illness when they are infected with the malaria parasite, while others carry the infection asymptomatically. An international team used mass cytometry &#8211; an in-depth way of characterising individual cells &#8211; and machine learning to discover &#8216;immune [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/new-insights-into-immune-responses-to-malaria/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174469</post-id>	</item>
		<item>
		<title>Research identifies potential role of &#8216;junk DNA&#8217; sequence in aging, cancer</title>
		<link>https://bioengineer.org/research-identifies-potential-role-of-junk-dna-sequence-in-aging-cancer/</link>
					<comments>https://bioengineer.org/research-identifies-potential-role-of-junk-dna-sequence-in-aging-cancer/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 14:34:23 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[Aging]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Genes]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[Gerontology]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Molecular Biology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/research-identifies-potential-role-of-junk-dna-sequence-in-aging-cancer/</guid>

					<description><![CDATA[Credit: Photo by Cori Kogan, WSU Health Sciences Spokane The human body is essentially made up of trillions of living cells. It ages as its cells age, which happens when those cells eventually stop replicating and dividing. Scientists have long known that genes influence how cells age and how long humans live, but how that [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/research-identifies-potential-role-of-junk-dna-sequence-in-aging-cancer/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174463</post-id>	</item>
		<item>
		<title>Phase two CD19-antibody-drug conjugate trial demonstrates promise for aggressive lymphoma</title>
		<link>https://bioengineer.org/phase-two-cd19-antibody-drug-conjugate-trial-demonstrates-promise-for-aggressive-lymphoma/</link>
					<comments>https://bioengineer.org/phase-two-cd19-antibody-drug-conjugate-trial-demonstrates-promise-for-aggressive-lymphoma/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 14:33:21 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/phase-two-cd19-antibody-drug-conjugate-trial-demonstrates-promise-for-aggressive-lymphoma/</guid>

					<description><![CDATA[MUSC Hollings Cancer Center part of promising clinical trial for aggressive lymphoma Credit: MUSC Hollings Emma C. Vought MUSC Hollings Cancer Center was one of 28 clinical sites around the world that participated in the LOTIS-2 trial to test the efficacy of Loncastuximab tesirine, a promising new treatment for aggressive B-cell lymphoma. The results of [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/phase-two-cd19-antibody-drug-conjugate-trial-demonstrates-promise-for-aggressive-lymphoma/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174461</post-id>	</item>
		<item>
		<title>Device cracks milk protein</title>
		<link>https://bioengineer.org/device-cracks-milk-protein/</link>
					<comments>https://bioengineer.org/device-cracks-milk-protein/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 14:22:07 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Alzheimer]]></category>
		<category><![CDATA[Biochemistry]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Cell Biology]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[neurobiology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/device-cracks-milk-protein/</guid>

					<description><![CDATA[&#8216;Refolding&#8217; molecules to support medical solutions Credit: Flinders University After gaining world attention by &#8216;unboiling&#8217; egg protein, Flinders University scientists have now used an Australian-made novel thin film microfluidic device to manipulate Beta-lactoglobulin (β-lactoglobulin), the major whey protein in cow&#8217;s, sheep&#8217;s and other mammals. The so-called Vortex Fluidic Device has previously been used in an [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/device-cracks-milk-protein/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174457</post-id>	</item>
		<item>
		<title>Chemotherapy can induce mutations that lead to pediatric leukemia relapse</title>
		<link>https://bioengineer.org/chemotherapy-can-induce-mutations-that-lead-to-pediatric-leukemia-relapse/</link>
					<comments>https://bioengineer.org/chemotherapy-can-induce-mutations-that-lead-to-pediatric-leukemia-relapse/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 13:36:25 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/chemotherapy-can-induce-mutations-that-lead-to-pediatric-leukemia-relapse/</guid>

					<description><![CDATA[A collaboration led by St. Jude Children&#8217;s Research Hospital, Shanghai Children&#8217;s Medical Center and others revealed how thiopurines produce mutations that lead to multi-drug resistant leukemia and relapse Credit: St. Jude Children&#8217;s Research Hospital Chemotherapy has helped make acute lymphoblastic leukemia (ALL) one of the most survivable childhood cancers. Now, researchers working in the U.S., [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/chemotherapy-can-induce-mutations-that-lead-to-pediatric-leukemia-relapse/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174447</post-id>	</item>
		<item>
		<title>Brain-repair discovery could lead to new epilepsy treatments</title>
		<link>https://bioengineer.org/brain-repair-discovery-could-lead-to-new-epilepsy-treatments/</link>
					<comments>https://bioengineer.org/brain-repair-discovery-could-lead-to-new-epilepsy-treatments/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 13:25:13 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[neurobiology]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<category><![CDATA[Trauma/Injury]]></category>
		<guid isPermaLink="false">https://bioengineer.org/brain-repair-discovery-could-lead-to-new-epilepsy-treatments/</guid>

					<description><![CDATA[Credit: Dan Addison &#124; UVA Communications University of Virginia School of Medicine researchers have discovered a previously unknown repair process in the brain that they hope could be harnessed and enhanced to treat seizure-related brain injuries. Common seizure-preventing drugs do not work for approximately a third of epilepsy patients, so new and better treatments for [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/brain-repair-discovery-could-lead-to-new-epilepsy-treatments/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174445</post-id>	</item>
	</channel>
</rss>
